randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als The Scientific and Therapeutic Rationale Off‐Label Treatments in Amyotrophic Lateral Sclerosis - Bedlack - 2025 The effects of l-Carnitine supplementation

The effects of l Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double blind, randomized, placebo controlled trial Clinical Nutrition ESPEN Randomised, double blind, placebo controlled, parallel group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study Journal of Neurology, Neurosurgery & Psychiatry The Scientific and Therapeutic Rationale for OffLabel Treatments in Amyotrophic Lateral Sclerosis Bedlack 2025 Annals of Neurology Wiley Online Library randomized double blind placebo controlled trial of acetyl l carnitine for als Clinical Evidence Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical A phase 1, randomized double blind, PDF) Acetyl L Carnitine (ALC) in Attention Deficit Hyperactivity Disorder: A Multi Site, Placebo Controlled Pilot Trial

SKU: 68910530210 · From condeoeiras.edu.pt